Skin conditions (dermatitis, eczema, psoriasis) decisions — 2026

The Board has remanded the case due to a lack of discussion on flares of skin conditions during the VA examination, and another examination is required.

The Veteran's pseudofolliculitis barbae is not manifest by characteristic lesions involving at least five percent of the entire body affected or exposed areas affected, and intermittent systemic therapy or other immunosuppressive drugs are not required. Therefore, a compensable rating for pseudofolliculitis barbae is denied.

The Veteran withdrew his appeals for service connection and rating increases, so the cases are dismissed.

The Board denied service connection for psoriasis and psoriatic arthritis, finding that the evidence did not support a causal relationship between these conditions and the Veteran's active service.

The Veteran's bilateral hearing loss has been rated as noncompensable and effective from February 21, 2023.,Service connection for a lumbar strain was granted with an effective date of June 7, 2021. The Veteran requested an earlier effective date but it was denied.,Obstructive sleep apnea (OSA) has been service connected and the effective date is August 8, 2022.,Depressive disorder received a grant with an effective date of June 7, 2021.,Service connection for BPPV was granted as secondary to migraines.,Right hip condition and left hip condition were denied service connection.,Acne, erectile dysfunction, scars, diabetes, left foot condition, right foot condition, and retina condition were all denied service connection.

The Board denied service connection for bilateral foot tinea pedis as there is no current diagnosis of the condition.

The Board has denied service connection for bilateral hearing loss, pseudofolliculitis barbae (shaving skin condition), and sinusitis as there is no current diagnosis of these conditions.,No VA examinations were conducted for the Veteran's back and neck disabilities.

The Board has granted service connection for a skin condition and denied service connection for acne. The Board also remanded other issues due to insufficient evidence or need for further examination.

The Board has decided to remand the case due to a need for an opinion on whether there is a nexus between the Veteran's folliculitis and acneform and his exposure to burn pits during military service. The claim will be reconsidered with this new information.

The appeal of the compensable disability rating for PFB is dismissed, and service connection for chronic sinusitis is denied.

The Veteran's claims for service connection for hypertension, allergic rhinitis, bilateral tinea pedis, and psoriasis have been granted. The Board has also remanded the issues of service connection for bilateral hip strain and seborrhea dermatitis.

The Board denied the Veteran's claim for an initial compensable rating for pseudofolliculitis barbae, finding that his condition did not meet the criteria for a compensable rating based on the lack of treatment and minimal affected area.

The Veteran's claim for an increased rating for COPD prior to October 21, 2024, and a higher rating from that date was denied. The Board found the evidence did not meet the criteria for a compensable or higher rating at any time during this period. For the period after October 21, 2024, the Veteran's COPD is rated as 30 percent disabling. The claim for TDIU was granted.

The Veteran's service connection claims for prostate cancer, psoriasis, recurrent intestinal disability, and bilateral hearing loss are granted due to the PACT Act presumption. The cases are remanded for further examination.

The Veteran's psoriasis scar with scaly hyperpigmentation behind left ear is granted a separate 10 percent rating. The Veteran's psoriasis scar with scaly hyperpigmentation behind right ear is granted a 10 percent rating.

The Veteran's appeal for chronic rhinitis and sarcoidosis was dismissed. The appeals for erectile dysfunction, skin condition, scar, fibromyalgia, headaches, bilateral hearing loss, CFS, dental abscess, visual acuity, memory loss condition, myocardial infraction, cardiovascular disease, sleep apnea, and diabetes mellitus were all dismissed.

The Veteran's varicose veins, right and left lower extremities, are now rated at 40 percent after April 16, 2019.,The Veteran's psoriasis with onychodystrophy, upper extremities and seborrheic dermatitis (psoriasis) is still rated at 10 percent prior to June 7, 2018.

The Veteran's dermatitis is currently rated at 30 percent, and the Board found that a higher rating is not warranted based on the evidence provided.

The Veteran's claims for increased ratings and service connection are remanded due to the need for additional evidence in several areas.

The Board has remanded the issues of entitlement to an effective date prior to June 23, 2023, for a 40 percent rating for right shoulder impingement syndrome (rotator cuff tendinopathy), and for an initial rating in excess of 10 percent for rhinitis.,The Veteran's claim for service connection for rhinitis was granted on a presumptive basis under the PACT Act, with an effective date set at August 10, 2022.